Concepedia

Weimin Kong

WK

Statistics

Publications

30

Citations

1.4K

H-Index

21

Active since

2003

Affiliations

China Pharmaceutical University(Current)

Temple University

University of Pennsylvania

Parker Institute for Cancer Immunotherapy

Indiana University

Weimin Kong is an author at China Pharmaceutical University specializing in life sciences, immunology, and inflammation.

ORCID

Publications per year

2003–2024

30

Publications

30

Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells

Sangya Agarwal, M. Ángela Aznar, Andrew J. Rech et al. · Immunity · 2023 · 166 citations · Full text

, , +17

Docosahexaenoic acid prevents dendritic cell maturation and in vitro and in vivo expression of the IL-12 cytokine family

Weimin Kong, Jui‐Hung Yen, Evros Vassiliou et al. · Lipids in Health and Disease · 2010 · 126 citations · Full text

, , +17

Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis

Weimin Kong, Jui‐Hung Yen, Doina Ganea · Brain Behavior and Immunity · 2010 · 121 citations · Full text

, , +14

Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS

Weimin Kong, Hongbo Li, Ronald F. Tuma et al. · Cellular Immunology · 2013 · 94 citations · Full text

, , +14

BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia

Weimin Kong, Alexander J. Dimitri, Wang Wenliang et al. · Journal of Clinical Investigation · 2021 · 94 citations · Full text

, , +17

1–5 of 30